  Proc. Nadl. Acad. Sci. USA
  Vol. 82, pp. 3785-3789, June 1985
  Genetics


  RAS2 Saccharomyces cerevisiae required gluconeogenic
  growth proper response nutrient limitation
       (yeast/oncogenes/sporulaion/storage carbohydrates)
  KELLY TATCHELL, Lucy C. ROBINSON, MICHAEL BREITENBACH*
  Department Biology, G5, University Pennsylvania, Philadelphia, PA 19104
  Communicated Edward M. Scolnick, February 15, 1985

  ABSTRACT         Saccharomyces cerevisiae contains genes                       substitute normal RAS genes yeast  remarkable homology members ras oncogene                             modified RAS] gene transform NIH-3T3 cells (11).
 family. genes, RAS] RAS2, constitute                                  Given functional biochemical similarities  essential gene family spores disruptions ofboth genes                    mammalian yeast RAS proteins, likely knowl-
 fail grow. report strains containing RAS2                           edge RAS function yeast direct implica-
 disruptions distinct phenotypes.  fail                     tions forRAS function mammals. report yeast
 grow efficiently nonfermentable carbon sources. Second,                          strains lacking RAS2 function defect gluconeogenic
 hyperaccumulate storage carbohydrates glycogen                         growth, accumulate excessive levels storage carbohy-
 trehalose.  diploid cells homozygous RAS2                             drates, sporulate prematurely. identified muta-
 disruptions sporulate rich media. Extragenic suppressors                         tions additional genes suppress  isolated suppress gluconeogenic defect.                          gluconeogenic defect. mutations allow strains
 suppressors fall complementation                          RAS grow.
 groups, mutations bypass normal require-
 ment RAS cell viability, allowing cells containing                                MATERIALS METHODS
 RAS gene grow. phenotype RAS2 mutant  extragenic suppressors unplicateRAS function                         Yeast Strains. TX2-530.1.1C  leu2 ura3 trpl lysi lys2 his3
 normal response nutrient limitation.                                             ras2-530) (4) backcrossed MCY638  his4-539 lys2-
                                                                                     801 ura3-52). MCY638 MCY317  ade2-101 his4-539),
 Saccharomyces cerevisiae contains genes pro-                            derived strain S288C, kindly provided Marian
 tein products share homology mammalian ras                                 Carlson. Meiotic segregants EG81, second backcross
                                                                                     MCY638, used quantitative measurements  oncogene products. YP2, located chromosome VI (1),                               revertant analysis. backcrosses performed  shares 40  homology NH2-terminal 160 amino                             linkage specific phenotypes ras2, mende-
 acids mammalian ras, RASI RAS2 (2),                                lian segregation patterns gluconeogenic defect  located chromosome XV (3, 4) XIV (3), respectively                           glycogen hyperaccumulation clearly observed origi-
 >60  homologous mammalian ras                                  nal transformed diploid TX2-530. Specific strains used 
 region (5, 6). RAS] RAS2 constitute essential gene                           clude EG81-40A  ura3 his4 lys2), EG81-40B  ras2-530
 family. Cells containing disruptions RAS gene                       leu2 ura3 his4 lys2 lysi), EG81-40C  ras2-530 leu2 ura3 his4
 viable, haploid spores containing disruptions                       lys2 his3 lysl?), EG81-40D  ura3 his4 lys2 his3 lysl?),
RAS] RAS2 fail grow (3, 4). YP2 fails complement                           EG81-22B  ras2-530 his4-539 lys2-801 ura3), 112-699   double disruption encodes separate                              leu2 ura3 can1-100 ade2-1 his3 ras2-699  )].
function.                                                                              gluconeogenic revertants described 
   RAS] RAS2 code proteins 309 322 amino                             rived EG81-22B. Revertants crossed EG72-16C
acids, respectively, immunoprecipitated                              ras2-530 leu2 trpl lys2) subsequent crosses antibodies directed mammalian p21 (7, 8). larger                        strains containing sra mutations meiotic
size proteins relative 21-kDa mammalian p21                         progeny crosses. EG73-14D  rasl-545 leu2 ura3 result 7-amino acid extension NH2-terminal                       lysi his3) EG87-2B  rasl-545 ura3 his4 lys2) used
end yeast proteins 120- 130-amino acid                             test sra mutations bypass RAS. XC0262485  insertion COOH-terminal portion proteins.                         rasl485 (Trp') stell'3 leu2 his4-580 his3 trpl] COOH-terminal insertions homologous                           described (7).
                                                                                       Media Genetic Techniques. Unless stated, location analogous position                        yeast cells grown 1  yeast extract 2  peptone
mammalian proteins greatest divergence (amino acids                            (YEP medium) containing 2  designated carbon
165-185).                                                                           source; glucose (YEPD medium), ethanol (YEPE
   Like mammalian counterparts, yeast RAS pro-                            medium), glycerol (YEPG medium), acetate (YEPA 
teins bind GTP (7, 8)  case RAS1,                       dium). Sporulation medium described (13). intrinsic GTPase activity similar p21 (9).                      Genetic techniques described Mortimer activity decreased absent RAS1 proteins contain-                      Hawthorne (14). Cell number determinations doubling
ing missense mutations amino acid positions analogous                         time calculations cells grown liquid culture transforming mutations p21 (9). Functional similarities                     using Klett colorimeter.
exist p21 yeast RAS. normal mammalian                                  Glycogen Trehalose Determinations. Qualitative glyco-
Harvey ras gene (10) viral Harvey ras (11)                               gen determinations routinely inverting plate publication costs article defrayed page charge          *Permanent address: Institut fur Allgemeine Biochemie und Ludwig
payment. article marked "advertisement"                Boltzmann Forschungsstelle fuir Biochemie, Universitdt Wien, accordance 18 U.S.C. §1734 solely indicate fact.                     Wahringerstrasse 38, 1090, Vienna, Austria.
                                                                             3785
3786     Genetics: Tatchell et al.                                                   Proc. Natl. Acad. Sci. USA 82 (1985)
 cells iodine vapors. Cells accumulate glycogen            defect, glycogen phenotype segregated LEU2
stain brown, don't remain yellow. Quan-             meiosis 52 tetrads remained associated titative trehalose glycogen determinations               ras2-530 backcrosses wild-type strain.
according Lillie Pringle (15).                                  Strain 112-699 (ras2-699) stained darker    DNA Isolation Southern Analysis. Genomic yeast DNA              congeneic RAS2 parent. Confirmation iodine stain isolated according Winston et al. (16). Gel electro-            reflected levels ofglycogen accomplished measur-
phoresis, DNA blotting, hybridization analysis              ing glycogen levels (15). EG81-40B -40C, scribed (4).                                                 contained ras2-530, significantly higher levels glyco-
                                                                       gen wild-type spore clones 40A 40D (Table 1).
                          RESULTS                                      Quantitative measurements storage carbohydrate,
                                                                       trehalose, showed trend.
   RAS2 Required Efficient Gluconeogenic Growth.                   observed diploids homozygous ras2 sporulated
RAS] RAS2 disrupted diploid strains                rich medium. strains Saccharomyces cerevisiae
inserting genes selectable auxotrophic markers, URA3               undergo meiotic cell cycle (referred sporula- LEU2, respectively, coding sequences               tion) medium deficient reduced nitrogen containing
cloned genes replacing normal genes                   nonfermentable carbon source acetate. series disrupted copies (3, 4). phenotypic change observed             strains, homozygous heterozygous wild-type haploid meiotic products contained disruptions              mutant RAS2 gene, tested sporulation different RAS] RAS2  observed               media. ras2 homozygous diploids (EG81-40B/EG81-
yeast cells containing disruptions RAS2 (allele ras2-530)           40C EG81-44A/EG81-44B) sporulated YEPD impaired ability grow nonfermentable carbon              YEPE medium (5-25 ). Heterozygous homozygous
sources ethanol, glycerol, acetate, pyruvate.              wild-type strains  closely related strains) showed independent ras2-530 mutants showed growth                   sporulation media 96 hr. strains
defect. defect segregated 2:2 meiosis LEU2            isogeneic, data sufficient prove
(ras2-530) 52 spored asci tested remained              genetic linkage derepressed sporulation pheno-
associated ras2 backcrosses wild-type          type ras2.  Toda et al. (17) recently
strain (MCY638). Strain 112-699 contains RAS2 gene                   observed similar phenotype independently construct-
disrupted HIS3 gene defect            ed ras2 mutations.
ras2-530 strains (11). congeneic RAS2 parent                   Increased Gene Dosage RASI Suppress Growth
defect. phenotypic changes associated            Defect ras2-530. Strain XC0262-485 contains multiple
disruptions RAS], yeast ras homolog.                      copies RAS] gene integrated RAS] locus (allele
   Growth ethanol glycerol completely elimi-             RAS1485) increased levels RAS] mRNA nated strains contain ras2-530. failed        protein (7). Strains containing ras2-530 RAS1485
grow nonfermentable carbon sources 37°C, significant             growth defect ethanol (YEPE medium). Tetrad
growth observed lower temperatures. Doubling times              analysis strains heterozygous ras2-530 representative RAS2 ras2-530 strains presented          RAS1485 revealed spore clones containing ras2-530
Table 1. Sister spores tetrad EG81-40, contained            RAS1485 (Leu+,Trp+) grew YEPE medium (total ras2-530 (EG81-40B -40C), longer doubling times                 35), spore clones containing ras2-530 RAS] wild-type spores (EG81-40A -40D) YEPE                   (total 27) failed grow. glycogen phenotype medium (ethanol) 21°C 30°C failed grow 37°C            ras2-530 suppressed RASS1485 allele. (doubling time >24 hr). difference growth rate            Leu+, Trp+ spore clones stained extent RAS2 ras2-530 strains observed YEPD                      iodine wild-type (Leu-) clones (data shown).
medium (glucose) 21°C 30°C, difference observed 37°C (Table 1). Transfer EG81-40B                      Gluconeogenic Defect Reverts High Frequency.
glucose ethanol medium resulted population largely           Numerous growing clones arose strains containing
unbudded cells, indicated cell cycle arrest G1.                ras2-530 cultured YEPE YEPG medium. order
EG81-40B failed grow glycerol, acetate, pyru-             characterize events responsible reversions,
vate did grow fermentable sugars sucrose                 individual colonies strain EG81-22B  ras2-530) raffinose. growth defect recessive diploids               grown stationary phase YEPD medium plated heterozygous ras2-530 grew ethanol glycerol.             YEPG medium. 7 days 37°C, growing colonies    ras2-530 Causes Derepression Sporulation Carbo-               observed frequency colony 104-105 cells
hydrate Accumulation. Yeast strains containing ras2-530                 plated. revertants crossed EG73-14D  consistently stained darker iodine wild-type                  ras2-530), resulting diploids utilize ethanol
 strains, suggested ras2-530 responsible         glycerol,   mutations
increased accumulation glycogen. Like gluconeogenic              responsible reversions dominant Table 1. Doubling times carbohydrate levels ras2-530 strains
                                                  Doubling time, min
                                  210C                   300C                  370C
               Relevant     YEPD       YEPG        YEPD       YEPE      YEPD        YEPE         Glycogen,               Trehalose,
  Strain      genotype medium medium medium medium medium medium pg/mg dry weight Ag/mg dry weight
EG81-40A        RAS2          240        408         90        198        117         480              9                       1
EG81-40B        ras2          215       1269         90        600        235      >2400*             93                     87
EG81-40C        ras2          240       1231         90        855        213      >2400             106                     99
EG81-40D        RAS2          240        426         96        198        153         450             18                      2
  Glycogen trehalose measurements early stationary-phase cultures.
 initial period growth, ras2 strains stopped growing 370C. growth pattern glycerol-, acetate-,  pyruvate-containing medium.
            Genetics: Tatchell et al.                                                        Proc. Natl. Acad. Sci. USA 82 (1985)           3787
           Table 2. Genetic analysis sra mutants
                                                                           Ethanol utilizing/ethanol nonutilizingt
                                                      Relevant                     spored asci                               ethanol
            Cross         Parental strains           genotype*         4:0       3:1     2:2        1:3     0:4     Total*       positive
            RX14        R12b/EG72-16C              sral-1/+              0         0      11         1       0       33/42          44
           RX1          Rla/EG72-16C               sral-2/+              0        0        4         0       0       14/18          44
           RX12         R2b/EG72-16C              sra2/+                 0        0        4         1       0       17/18          49
           RX8          R6e/EG72-16C              sra3/+                 0        0        4         0       1      12/19           39
           RX26        RX14-7B/RX14-4D            sral-1/sral-1                                Sporulation negative
           RX15        RX1-1B/RXI-6C              sral-2/sral-2         16        0        0         0       0      77/0           100
           RX16        RX14-7B/RX1-lB             sral-J/sral-2          2        0        0         0       0      38/0           100
           RX19        RX12-1B/RX12-3D            sra2/sra2              5        0        0         0       0      29/0           100
           RX20        RX8-9B/RX8-9C              sra3/sra3             10        0        0        0        0      69/0           100
           RX45        RX31-12B/RX12-4A           sral sra2            0        3        2        0        0      38/23           62
           RX18        RX1-2D/RX12-1B             sral-2/sra2            2        7        2        0       0       54/18           75
           RX58        RX14-1C/RX8-9C             sral-1/sra3            1        3        1        0       0       44/16           73
           RX21        RX1-lB/RX8-9B              sral-2/sra3            2      14         2        0       0       58/22           72
           RX43        RX12-4A/RX8-7B             sra2/sra3              1        0        1        0       0       23/10           70
           *A11 strains contain ras2-530 mutation.
           tGrowth ethanol scored 48 hr 30°C YEPE medium.
           tA high percentage spores failed germinate (>40 ) crosses (RX16 RX43, example)             data tetrad analysis significant. reason, data germinating spores included.

  recessive. preliminary characterization chose                  pleiotropic phenotypes observed strains 
  look recessive revertants.                                   tain sral independent ras2-530.      mutations responsible reversion                     obtained sral-l strains wild type RAS2   gluconeogenic deficiency segregated mendelian genes,                observed phenotypes original revertant
  shown 2:2 segregation ethanol growth tetrads                (Rl2b)  accumulation brown pigment, lack   strains heterozygous suppressors (Table 2).               glycogen, loss viability nitrogen-deficient media.
  placed mutations responsible suppression                 inability R12b grow ethanol 37°C   (designated sra "suppressor ras") complemen-               shared sral-J strains wild type RAS2. failure   tation groups crossing different suppressors observing             R12b grow ethanol 37°C failure sral-J
  ability meiotic progeny utilize ethanol glycerol.            suppress gluconeogenic defect ras2-530   summary crosses presented Table 2.                 phenotype sral-l itself.
  suppressors revertants R12b Rla   complementation group, suppressors                                                     .0           -0
  revertants, R2b R6e, fell different                                                      L-    CNJ        N     CD
 complementation groups. Crosses suppressors                                                        EE    cr    cr     cr
 R2b, R6e, R12b Rla gave rise -25 
 YEPE- progeny (original SRA ras2 phenotype). data                                 YEPD 300E
 presented Table 2 crosses RX45, RX18, RX58,
 RX21, RX43. designated suppressors R12b,                              YEPD/ 12 stain
 Rla, R2b, R6e sral-J, sral-2, sra2, sra3, respec-
 tively.
    revertants phenotypes addition                               YEPE 30°0
 reversion gluconeogenic defect.  documented Fig. 1, parent congeneic
 revertants spotted YEPD medium replica-                              YEPE 370
 plated different media. determined iodine stain-
 ing, R12b Rla accumulated glycogen parent.
 R6e,  accumulated high higher levels                            YEPG 300
parent. revertants grew better parent YEPE YEPG medium 30°C, R12b failed grow                                     YEPG 370
YEPE medium 37°C. growth defect observed YEPG (Fig. 1) YEPA medium (data shown). phenotype specific R12b Rla decreased                             -NH;/YEPD
viability grown medium deficient (NH4)2SO4. observed strains replica-plated                       FIG. 1. Pleiotropic phenotyes sra mutations. Strain EG81-
(NH4)2SO4-deficient medium, incubated 48 hr                  22B (parent) revertants ras2 gluconeogenic defect
plated rich medium (YEPD medium). seen                    spotted YEPD plate, allowed grow 24 hr 30C, panel Fig. 1, R12b Rla, contain             replica-plated media listed left, photographed
alleles sral, showed decreased plating efficiency com-               48 hr. second row, glycogen content estimated pared strains. R12b meiotic progeny              staining cells iodine vapor. row, colonies containing sral-1 accumulated brown pigment incu-                  incubated minimal medium lacking (NH4)2SO4 48 hr, replica-
bated extended periods time. Spectroscopic examina-                plated YEPD medium, photographed 24 hr 30°C.
                                                                          cells R12b Rla nonviable incubation tion strain (data shown) revealed absorption                (NH4)2SO4-deficient media, seen decreased plating
band 580-590 nm, indicative porphyrin compound (18).              efficiency.
3788     Genetics: Tatchell et al.                                                Proc. Natl. Acad. Sci. USA 82 (1985)

  observed strains homozygous sral-J failed          shown recently bypass requirement RAS
sporulate.  sral-2, appeared allelic         (17). know bcyl allelic sral. gici, mutation
sral-J shared phenotypes, sporulated           originally characterized glycogen deficiency (12), like homozygous heteroallelic sral-1.             sral, recessive sporulation defect accumulates consistent generally weaker phenotype               brown porphyrin pigment (26) does appear sral-2. Strains containing sral-2 accumulated glyco-           allelic sral (unpublished data).
gen, did turn brown storage sral-1,                 Yeast cells normally grow unrestrained unless deprived showed slightly increased viability sral-J NH4)2SO4-        essential nutrients. situations cell cycle
deficient media (Fig. 1). observed sporulation        inhibited, response haploid cells mating
defect suppressors.                                    hormones, cell growth continues (27).   Extragenic Revertants Bypass Requirement ras.         responses deprivation nutrients accumulation Haploid spores containing disruptions rasi ras2         storage carbohydrates, glycogen trehalose. fail germinate arrest early cell cycle prior    case glucose limitation, accumulation begins bud emergence (3, 4). sra mutations suppressed         consumption glucose growth gluconeogenic defect ras2, asked            medium, cells growing logarithmically (15).
bypass requirement RAS altogether.         carbon source finally depleted cells arrest crossing strains containing ras2-530 (marked LEU2)           G1 cell cycle, giving rise population largely
sra strains containing rasl-545 disruption (marked         unbudded cells. Deprivation reduced nitrogen, phosphate, URA3). Haploid meiotic progeny containing ras2          sulfate elicits similar response (15). diploid cells,
rasi (Leu', Ura') viable spore              induction meiotic cell cycle, sporulation, clones sra mutation eliminates bypasses require-      governed nutrient levels. strains, nitrogen ment RAS genes. case          glucose eliminated sporulation occur. sral-l sra3. rasi, ras2 double mutants (Leu+, Ura+)        Optimal sporulation occurs acetate buffer. strains frequently sral-l sra3                induced sporulate limiting phosphate sulfate
present, indicates mutations eliminated        instead nitrogen (28).
requirement normally essential RAS genes. Ura+,            increased glycogen levels derepressed sporulation
Leu+ spore clones sral-l crosses phenotypes            ras2-530 strains taken evidence RAS
indicative sral-l (glycogen deficiency, pigment accumula-        function nutritional assessment  specifically,
tion, decreased viability (NH4)2SO4-deficient media).        lack RAS2 results premature starvation cold-sensitive phenotype, growing              response. decreased RAS expression leads premature 30°C growing poorly 25°C. putative        starvation response, overexpression decrease elimi-
rasi ras2 sra3 strains grew poorly temperatures. Ura+,       nate response. Strains carrying RAS2 missense muta-
Leu+ spores observed sral-2 sra2            tion, resulting substitution valine-19 glycine-19, present.                                                        dominant phenotype consistent inability    ruled duplication RASI explanation        respond starvation conditions; strains (RAS2 vall9) fail apparent bypass phenotype sral-J sra3             sporulate (3), fail accumulate glycogen trehalose,
Southern hybridization analysis. Genomic DNA isolated           decreased viability (17). confirmed sral sra3 strains, digested proper restric-       observations strain containing RAS2alal6vall9 (unpub-
tion endonucleases distinguish wild-type mutant         lished data). mutations result decrease RAS alleles, electrophoresed agarose, blotted          intrinsic GTPase activity RAS2 protein affect-
nitrocellulose, hybridized nick-translated RAS]         ing GTP binding, RAS1 gene product (9), RAS2 DNA (4). case did observe additional bands            net result analogous overexpression RAS. ras hybridization indicative additional RAS gene.       similarities sral-1 RAS2Vall9 phenotypes,
rasi, ras2 sra mutants contained restriction pattern       observation sral-1 bypasses disruption alleles (data shown).                         requirement RAS, suggest sral gene products
                                                                     acting downstream RAS pathway.
                        DISCUSSION                                     phenotypes described implicate RAS2                                                                     function response nutrient levels, mechanism number previously characterized mutations yeast              signaling clear.  cAMP metabolism appears phenotypes similar ones discussed  spd         involved. Strains mutations CYR], mutations described Dawes Calvert (19, 20) sporulate          deficient adenylate cyclase activity, hypersporulate,
efficiently rich medium fail grow effectively           bcyl mutants asporogenous (22). nonfermentable carbon sources. Unlike ras2, grow           evidence enzymes responsible synthesis fail sporulate medium containing ethanol       degradation glycogen trehalose regulated sole carbon source. temperature-sensitive cell division          phosphorylation (25, 29-33). cAMP-dependent protein
cycle mutants, cdc25 cdc35, derepressed             kinase directly implicated stimulation trehalase
sporulation (21) cyrl (22), maps close           phosphorylase (25, 33). Taken  results
cdc35 results loss adenylate cyclase activity (23).    suggest testable hypothesis RAS functions    spd mutations, like ras2, revert glycerol utilization     mechanism regulating protein kinases.
high frequency, extragenic suppressors. sup-              understand strains lacking RAS2 pressors share similarities sral-l (24).        defect gluconeogenic growth.  defect recessive asporogenous phenotype, decreased vi-               allowed isolate suppressors bypass normal
ability, accumulate brown pigment incubated           requirement RAS. Judging similarities phe-
extended periods. Unlike sral,  spd suppressors          notypes sral-l dominant RAS2 mutation, dominant suppression respiratory defect.         likely sral-l function downstream additional mutations similar phenotypes sral-1 . bcyl,      pathway. recent observations mammalian (10) mutation leading loss cAMP dependence               viral Harvey ras (11) substitute normal
normal cAMP-dependent protein kinase (23), shares                 RAS genes yeast modified RAS] gene number phenotypes sral-J. bcyl recessive               transform NIH-3T3 cells (11) support hypothesis sporulation defect (22), fails accumulate trehalose (25),     RAS equivalent functions organisms.            Genetics: Tatchefl et aL                                                         P1oc. NatL. Acad. Sci. USA 82 (1985)        3789

 case, sra bypass mutants described                           eds. Rose,  H. & Harrison, J. S. (Academic, New York),
 functional equivalents mammals. Molecular cloning                         Vol, 1, pp. 385-460.
 suppressors allow isolation oftheir mammalian              15.    Lillie, S. H. & Pringle, J. R. (1980) J. Bacteriol. 143,
 counterparts lead understanding RAS                           1384-1394.
 function.                                                                16.    Winston, F., Chumley, F. & Fink, G. R. (1983) Methods
                                                                                 Enzymol. 101, 211-228.
                                                                          17.    Toda, T., Uno, , Ishikawa, T., Powers, S., Kataoka, T.,
    thank Deborah DeFeo-Jones, John Cannon, Richard                       Broek, D., Cameron, S., Broach, J., Matsumoto, K. & Wigler,
 Schultz helpful discussions. thank Ian Dawes bringing           M. (1985) Cell 40, 27-36.
 attention similarities betweefl phenotypes         18.    Pretlo*, T. P. & Sherman, F. (1967) Biochim. Biophys. Acta
 mutations RAS SPD. work supported grants                148, 629-644.
 General Medical Council (GM29473) National Cancer                19.    Dawes,  W. (1975) Nature (London) 255, 707-708.
 Institute (CA37702) National Institutes Health. L.C.R.     20.    Dawes,  W. & Calvert, G. R. (1984) J. Gen. Microbiol. 130,
 supported National Institutes Health predoctoral training grant           605-613.
 M.B. supported Max Kade Fellowship.                 21. Shilo, V., Shimchen, G. & Shilo, B., (1978) Exp. Cell Res. 112,
                                                                                 141-248.
   1. Gallwitz, D., Donath, C. & Sander, C. (1983) Nature (London)        22. Matsumoto, K., Uno,  & Ishikawa, T. (1983) Cell 32,
       306, 704-707.                                                           417-423.
   2. DeFeo-Jones, D., Scolnick, E. M., Koller, R. & Dahr, R.             23. Matsumoto, K., Uno, , Oshima, Y. & Ishikawa, T. (1982)
       (1983) Nature (London) 306, 707-709.                                    Proc. Natd. Acad. Sci. USA 79, 2355-2359.
   3. Kataoka, T., Powers, S., McGill, C., Fasano, O., Strathern,         24. Calvert, G. R. & Dawes,  W. (1984) J. Gen. Microbiol. 130,
       J., Broach, J. & Wigler, M. (1984) Cell 37, 437-445.                    615-624.
  4. Tatchell, K., Chaleff, D. T., DeFeo-Jones, D. & Scolnick,            25. Uno, , Matsumoto, K., Adachi, K. & Ishikawa, T. (1983) J.
       E. M. (1984) Nature (London) 309, 523-527.                              Biol. Chem. 258, 10867-10872.
  5. Dahr, R., Nieto, , Koller, R., DeFeo-Jones, D. & Scolnick,         26. Padrao, G. R. B., Malamud, D. R., Panek,  D. & Mattoon,
       E. M. (1984) Nucleic Acids Res. 12, 3611-3618.                          J. R. (1982) Mol. Gen. Genet. 185, 255-261.
  6. Powers, S., Kataoka, T., Fasano, O., Goldfarb, M., Broach, J,        27. Thorner, 3. (1981) Molecular Biology Yeast
       & Wigler, M. (1984) Cell 36, 607-612.                                   Saccharomyces: Life Cycle Inheritance, eds. Strathern,
  7. Temeles, G. L., DeFeo-Jones, D., Tatchell, K., Ellinger,                 J. N., Jones, E. W. & Broach, J. R. (Cold Spring Harbor
       M. S. & Scolnick, E. M. (1984) Mol. Cell. Biol. 4, 2298-2305.          Laboratory, Cold Spring Harbor, NY), pp. 143-180.
  8. Tamanoi, F., Walsh, M., Kataoka, T. & Wigler, M. (1984)             28. Freese, E. B., Chu, M.  & Freese, E. (1982) J. Bacteriol.
      Proc. Natd. Acad. Sci. USA X1, 6924-6928.                               149, 840-851.
  9. Temeles, G. L., GibbS, J. B., D'Alonzo, J. S., Sigal,  S. &       29. Fosset, M., Muir, L. W., Nielsen, L. D. & Fischer, E. H.
      Scolnick, E. M. (1985) Nature (London) 313, 700-703.                    (1971) Biochemistry 10, 4105-4113.
10. Kataoka, T., Powers, S., Cameron, S., Fasano, O., Goldfarb,          30. Huang, K. P. & Cabib, E. (1974) J. Biol. Chem. 249,
      M., Broach, J. & Wigler, M. (1985) Cell 140, 19-26.
11. DeFeo-Jones, D., Tatchell, K., Robinson, L. C., Sigal, ,                3851-3857.
      Vass, W., Lowy, D. R. & Scolnick, E. M. (1985) Science 228,        31. van Solingen, P. & van der Plaat, J. 13. (1975) Biochem.
      179-184.                                                                Biophys. Res. Commun. 62, 553-560.
12. Rothman-Denes, L. B. & Cabib, E. (1970) Proc. Ndtl. Acad.            32. Ortiz, C. H., Maia, J. C. C., Tenan, M. M., Braz-Padrao,
      Sci. USA 66, 967-974.          